Cargando…

Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study

This work presents a comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film measurements with a commercial treatment planning system to determine the feasibility of PRESAGE® for 3D dosimetry in breast IMRT. An anthropomorphic PRESAGE® phantom was created in the shape of a breast p...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Khalid, Gifford, Kent A, Ibbott, Geoffrey, Grant, Ryan L, Buzdar, Saeed Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711233/
https://www.ncbi.nlm.nih.gov/pubmed/24423854
http://dx.doi.org/10.1120/jacmp.v15i1.4531
_version_ 1783283038771216384
author Iqbal, Khalid
Gifford, Kent A
Ibbott, Geoffrey
Grant, Ryan L
Buzdar, Saeed Ahmad
author_facet Iqbal, Khalid
Gifford, Kent A
Ibbott, Geoffrey
Grant, Ryan L
Buzdar, Saeed Ahmad
author_sort Iqbal, Khalid
collection PubMed
description This work presents a comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film measurements with a commercial treatment planning system to determine the feasibility of PRESAGE® for 3D dosimetry in breast IMRT. An anthropomorphic PRESAGE® phantom was created in the shape of a breast phantom. A five‐field IMRT plan was generated with a commercially available treatment planning system and delivered to the PRESAGE® phantom. The anthropomorphic PRESAGE® was scanned with the Duke midsized optical CT scanner (DMOS‐RPC) and the OD distribution was converted to dose. Comparisons were performed between the dose distribution calculated with the Pinnacle(3) treatment planning system, PRESAGE®, and EBT2 film measurements. DVHs, gamma maps, and line profiles were used to evaluate the agreement. Gamma map comparisons showed that Pinnacle(3) agreed with PRESAGE® as greater than 95% of comparison points for the PTV passed a [Formula: see text] criterion when the outer 8 mm of phantom data were discluded. Edge artifacts were observed in the optical CT reconstruction, from the surface to approximately 8 mm depth. These artifacts resulted in dose differences between Pinnacle(3) and PRESAGE® of up to 5% between the surface and a depth of 8 mm and decreased with increasing depth in the phantom. Line profile comparisons between all three independent measurements yielded a maximum difference of 2% within the central 80% of the field width. For the breast IMRT plan studied, the Pinnacle(3) calculations agreed with PRESAGE® measurements to within the [Formula: see text] gamma criterion. This work demonstrates the feasibility of the PRESAGE® to be fashioned into anthropomorphic shape, and establishes the accuracy of Pinnacle(3) for breast IMRT. Furthermore, these data have established the groundwork for future investigations into 3D dosimetry with more complex anthropomorphic phantoms. PACS number: 87.53.Jw, 87.55.D‐, 87.55.dk
format Online
Article
Text
id pubmed-5711233
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57112332018-04-02 Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study Iqbal, Khalid Gifford, Kent A Ibbott, Geoffrey Grant, Ryan L Buzdar, Saeed Ahmad J Appl Clin Med Phys Radiation Measurements This work presents a comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film measurements with a commercial treatment planning system to determine the feasibility of PRESAGE® for 3D dosimetry in breast IMRT. An anthropomorphic PRESAGE® phantom was created in the shape of a breast phantom. A five‐field IMRT plan was generated with a commercially available treatment planning system and delivered to the PRESAGE® phantom. The anthropomorphic PRESAGE® was scanned with the Duke midsized optical CT scanner (DMOS‐RPC) and the OD distribution was converted to dose. Comparisons were performed between the dose distribution calculated with the Pinnacle(3) treatment planning system, PRESAGE®, and EBT2 film measurements. DVHs, gamma maps, and line profiles were used to evaluate the agreement. Gamma map comparisons showed that Pinnacle(3) agreed with PRESAGE® as greater than 95% of comparison points for the PTV passed a [Formula: see text] criterion when the outer 8 mm of phantom data were discluded. Edge artifacts were observed in the optical CT reconstruction, from the surface to approximately 8 mm depth. These artifacts resulted in dose differences between Pinnacle(3) and PRESAGE® of up to 5% between the surface and a depth of 8 mm and decreased with increasing depth in the phantom. Line profile comparisons between all three independent measurements yielded a maximum difference of 2% within the central 80% of the field width. For the breast IMRT plan studied, the Pinnacle(3) calculations agreed with PRESAGE® measurements to within the [Formula: see text] gamma criterion. This work demonstrates the feasibility of the PRESAGE® to be fashioned into anthropomorphic shape, and establishes the accuracy of Pinnacle(3) for breast IMRT. Furthermore, these data have established the groundwork for future investigations into 3D dosimetry with more complex anthropomorphic phantoms. PACS number: 87.53.Jw, 87.55.D‐, 87.55.dk John Wiley and Sons Inc. 2014-01-06 /pmc/articles/PMC5711233/ /pubmed/24423854 http://dx.doi.org/10.1120/jacmp.v15i1.4531 Text en © 2014 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Measurements
Iqbal, Khalid
Gifford, Kent A
Ibbott, Geoffrey
Grant, Ryan L
Buzdar, Saeed Ahmad
Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title_full Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title_fullStr Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title_full_unstemmed Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title_short Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
title_sort comparison of an anthropomorphic presage® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast imrt: a feasibility study
topic Radiation Measurements
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711233/
https://www.ncbi.nlm.nih.gov/pubmed/24423854
http://dx.doi.org/10.1120/jacmp.v15i1.4531
work_keys_str_mv AT iqbalkhalid comparisonofananthropomorphicpresagedosimeterandradiochromicfilmwithacommercialradiationtreatmentplanningsystemforbreastimrtafeasibilitystudy
AT giffordkenta comparisonofananthropomorphicpresagedosimeterandradiochromicfilmwithacommercialradiationtreatmentplanningsystemforbreastimrtafeasibilitystudy
AT ibbottgeoffrey comparisonofananthropomorphicpresagedosimeterandradiochromicfilmwithacommercialradiationtreatmentplanningsystemforbreastimrtafeasibilitystudy
AT grantryanl comparisonofananthropomorphicpresagedosimeterandradiochromicfilmwithacommercialradiationtreatmentplanningsystemforbreastimrtafeasibilitystudy
AT buzdarsaeedahmad comparisonofananthropomorphicpresagedosimeterandradiochromicfilmwithacommercialradiationtreatmentplanningsystemforbreastimrtafeasibilitystudy